{"count": 30, "results": [{"_id": "34983554", "pmid": 34983554, "pmcid": "PMC8725360", "title": "Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma", "journal": "J Nanobiotechnology", "authors": ["Yu Z", "Guo J", "Liu Y", "Wang M", "Liu Z", "Gao Y", "Huang L"], "date": "2022-01-04T00:00:00Z", "doi": "10.1186/s12951-021-01205-8", "meta_date_publication": "2022 Jan 4", "meta_volume": "20", "meta_issue": "1", "meta_pages": "9", "score": 50283.72, "text_hl": "Nano delivery of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ targets liver sinusoidal endothelial cells to remodel @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ microenvironment for @<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@hepatocellular carcinoma@@@", "citations": {"NLM": "Yu Z, Guo J, Liu Y, Wang M, Liu Z, Gao Y, Huang L. Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma J Nanobiotechnology. 2022 Jan 4;20(1):9. PMID: 34983554", "BibTeX": "@article{34983554, title={Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma}, author={Yu Z and Guo J and Liu Y and Wang M and Liu Z and Gao Y and Huang L}, journal={J Nanobiotechnology}, volume={20}, number={1}, pages={9}}"}}, {"_id": "36367620", "pmid": 36367620, "pmcid": "PMC9928804", "title": "Simvastatin Induces Apoptosis And Suppresses Hepatocellular Carcinoma Induced In Rats", "journal": "Appl Biochem Biotechnol", "authors": ["Elleithi YA", "El-Gayar AM", "Amin MN"], "date": "2023-03-01T00:00:00Z", "doi": "10.1007/s12010-022-04203-0", "meta_date_publication": "2023 Mar", "meta_volume": "195", "meta_issue": "3", "meta_pages": "1656-1674", "score": 50283.254, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Induces Apoptosis And Suppresses @<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@Hepatocellular Carcinoma@@@ Induced In Rats", "citations": {"NLM": "Elleithi YA, El-Gayar AM, Amin MN. Simvastatin Induces Apoptosis And Suppresses Hepatocellular Carcinoma Induced In Rats Appl Biochem Biotechnol. 2023 Mar;195(3):1656-1674. PMID: 36367620", "BibTeX": "@article{36367620, title={Simvastatin Induces Apoptosis And Suppresses Hepatocellular Carcinoma Induced In Rats}, author={Elleithi YA and El-Gayar AM and Amin MN}, journal={Appl Biochem Biotechnol}, volume={195}, number={3}, pages={1656-1674}}"}}, {"_id": "33424274", "pmid": 33424274, "pmcid": "PMC7783227", "title": "Developed simvastatin chitosan nanoparticles co-crosslinked with tripolyphosphate and chondroitin sulfate for ASGPR-mediated targeted HCC delivery with enhanced oral bioavailability", "journal": "Saudi Pharm J", "authors": ["Faris TM", "Harisa GI", "Alanazi FK", "Samy AM", "Nasr FA"], "date": "2020-12-01T00:00:00Z", "doi": "10.1016/j.jsps.2020.11.012", "meta_date_publication": "2020 Dec", "meta_volume": "28", "meta_issue": "12", "meta_pages": "1851-1867", "score": 50279.76, "text_hl": "In this context, repurposing @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SV@@@), a statin member, as an anticancer agent for the treatment of @<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@hepatocellular carcinoma@@@ (@<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@HCC@@@) has caught researchers' attention (; B.). ", "citations": {"NLM": "Faris TM, Harisa GI, Alanazi FK, Samy AM, Nasr FA. Developed simvastatin chitosan nanoparticles co-crosslinked with tripolyphosphate and chondroitin sulfate for ASGPR-mediated targeted HCC delivery with enhanced oral bioavailability Saudi Pharm J. 2020 Dec;28(12):1851-1867. PMID: 33424274", "BibTeX": "@article{33424274, title={Developed simvastatin chitosan nanoparticles co-crosslinked with tripolyphosphate and chondroitin sulfate for ASGPR-mediated targeted HCC delivery with enhanced oral bioavailability}, author={Faris TM and Harisa GI and Alanazi FK and Samy AM and Nasr FA}, journal={Saudi Pharm J}, volume={28}, number={12}, pages={1851-1867}}"}}, {"_id": "37393552", "pmid": 37393552, "pmcid": "PMC10661961", "title": "Association between Statins Types with Incidence of Liver Cancer: An Updated Meta-analysis", "journal": "Curr Med Chem", "authors": ["Zhang X", "Lou D", "Fu R", "Wu F", "Zheng D", "Ma X"], "date": "2023-06-30T00:00:00Z", "doi": "10.2174/0929867330666230701000400", "meta_date_publication": "2023 Jun 30", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50273.46, "text_hl": "Besides, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ can induce apoptosis of @<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@liver cancer@@@ cells and impair cell cycle progression. ", "citations": {"NLM": "Zhang X, Lou D, Fu R, Wu F, Zheng D, Ma X. Association between Statins Types with Incidence of Liver Cancer: An Updated Meta-analysis Curr Med Chem. 2023 Jun 30;():. PMID: 37393552", "BibTeX": "@article{37393552, title={Association between Statins Types with Incidence of Liver Cancer: An Updated Meta-analysis}, author={Zhang X and Lou D and Fu R and Wu F and Zheng D and Ma X}, journal={Curr Med Chem}}"}}, {"_id": "36536645", "pmid": 36536645, "pmcid": "PMC9759026", "title": "A Novel Gene Signature Associated with Inflammatory Responses and Immune Status Assists in Prognosis and Intervention for Patients with HCC", "journal": "J Inflamm Res", "authors": ["Lu G", "Du R", "Feng B", "Wang J", "Zhang F", "Pei J", "Wang Y", "Shang Y"], "date": "2022-12-13T00:00:00Z", "doi": "10.2147/JIR.S390113", "meta_date_publication": "2022", "meta_volume": "15", "meta_issue": "", "meta_pages": "6729-6743", "score": 50270.293, "text_hl": "Lastly, we validated that @CHEMICAL_Bleomycin @CHEMICAL_MESH:D001761 @@@bleomycin@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Zoledronic_Acid @CHEMICAL_MESH:D000077211 @@@zoledronate@@@ could regulate these genes in @<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@HCC@@@.", "citations": {"NLM": "Lu G, Du R, Feng B, Wang J, Zhang F, Pei J, Wang Y, Shang Y. A Novel Gene Signature Associated with Inflammatory Responses and Immune Status Assists in Prognosis and Intervention for Patients with HCC J Inflamm Res. 2022;15():6729-6743. PMID: 36536645", "BibTeX": "@article{36536645, title={A Novel Gene Signature Associated with Inflammatory Responses and Immune Status Assists in Prognosis and Intervention for Patients with HCC}, author={Lu G and Du R and Feng B and Wang J and Zhang F and Pei J and Wang Y and Shang Y}, journal={J Inflamm Res}, volume={15}, pages={6729-6743}}"}}, {"_id": "32000827", "pmid": 32000827, "pmcid": "PMC6993409", "title": "Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1alpha/PPAR-gamma/PKM2-mediated glycolysis", "journal": "J Exp Clin Cancer Res", "authors": ["Feng J", "Dai W", "Mao Y", "Wu L", "Li J", "Chen K", "Yu Q", "Kong R", "Li S", "Zhang J", "Ji J", "Wu J", "Mo W", "Xu X", "Guo C"], "date": "2020-01-30T00:00:00Z", "doi": "10.1186/s13046-020-1528-x", "meta_date_publication": "2020 Jan 30", "meta_volume": "39", "meta_issue": "1", "meta_pages": "24", "score": 50260.625, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ re-sensitizes @<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@hepatocellular carcinoma@@@ cells to @CHEMICAL_Sorafenib @CHEMICAL_MESH:D000077157 @@@sorafenib@@@ by inhibiting @GENE_HIF1A @GENE_15251 @@@HIF-1alpha@@@/@GENE_PPARG @GENE_19016 @@@PPAR-gamma@@@/@GENE_PKM @GENE_18746 @@@PKM2@@@-mediated glycolysis", "citations": {"NLM": "Feng J, Dai W, Mao Y, Wu L, Li J, Chen K, Yu Q, Kong R, Li S, Zhang J, Ji J, Wu J, Mo W, Xu X, Guo C. Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1alpha/PPAR-gamma/PKM2-mediated glycolysis J Exp Clin Cancer Res. 2020 Jan 30;39(1):24. PMID: 32000827", "BibTeX": "@article{32000827, title={Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1alpha/PPAR-gamma/PKM2-mediated glycolysis}, author={Feng J and Dai W and Mao Y and Wu L and Li J and Chen K and Yu Q and Kong R and Li S and Zhang J and Ji J and Wu J and Mo W and Xu X and Guo C}, journal={J Exp Clin Cancer Res}, volume={39}, number={1}, pages={24}}"}}, {"_id": "37208857", "pmid": 37208857, "title": "Size-optimized simvastatin-loaded TPGS modified lipid nanocapsules for targeting epithelial-to-mesenchymal transition in hepatocellular carcinoma: Role of PTEN/AKT signaling.", "journal": "Expert Opin Drug Deliv", "authors": ["Mahmoud K", "Teaima M", "Attia Y", "El-Nabarawi M", "Swidan S"], "date": "2023-05-01T00:00:00Z", "doi": "10.1080/17425247.2023.2216451", "meta_date_publication": "2023 May", "meta_volume": "20", "meta_issue": "5", "meta_pages": "703-719", "score": 50255.07, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SIM@@@-LNC50 also alleviated the migratory potential of @<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@HCC@@@ cells. ", "citations": {"NLM": "Mahmoud K, Teaima M, Attia Y, El-Nabarawi M, Swidan S. Size-optimized simvastatin-loaded TPGS modified lipid nanocapsules for targeting epithelial-to-mesenchymal transition in hepatocellular carcinoma: Role of PTEN/AKT signaling. Expert Opin Drug Deliv. 2023 May;20(5):703-719. PMID: 37208857", "BibTeX": "@article{37208857, title={Size-optimized simvastatin-loaded TPGS modified lipid nanocapsules for targeting epithelial-to-mesenchymal transition in hepatocellular carcinoma: Role of PTEN/AKT signaling.}, author={Mahmoud K and Teaima M and Attia Y and El-Nabarawi M and Swidan S}, journal={Expert Opin Drug Deliv}, volume={20}, number={5}, pages={703-719}}"}}, {"_id": "39866231", "pmid": 39866231, "title": "Chitosan capped-NLCs enhanced codelivery of gefitinib and simvastatin into MDR HCC: impact of compositions on cell death, JNK3, and Telomerase.", "journal": "Oncol Res", "authors": ["Harisa GI", "Alzhrani RF", "Alluhaidan AA", "Alamri SM", "Bakheit AH", "Asiri HH", "Attia SM"], "date": "2025-01-16T00:00:00Z", "doi": "10.32604/or.2024.053337", "meta_date_publication": "2025", "meta_volume": "33", "meta_issue": "2", "meta_pages": "477-492", "score": 50249.785, "text_hl": "This study aims to engineer @CHEMICAL_Chitosan @CHEMICAL_MESH:D048271 @@@chitosan@@@-coated nanostructure @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ carriers (NLCs) loaded with @CHEMICAL_Gefitinib @CHEMICAL_MESH:D000077156 @@@gefitinib@@@ (@CHEMICAL_Gefitinib @CHEMICAL_MESH:D000077156 @@@GF@@@) and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SV@@@) as CCT for @<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@HCC@@@. ", "citations": {"NLM": "Harisa GI, Alzhrani RF, Alluhaidan AA, Alamri SM, Bakheit AH, Asiri HH, Attia SM. Chitosan capped-NLCs enhanced codelivery of gefitinib and simvastatin into MDR HCC: impact of compositions on cell death, JNK3, and Telomerase. Oncol Res. 2025;33(2):477-492. PMID: 39866231", "BibTeX": "@article{39866231, title={Chitosan capped-NLCs enhanced codelivery of gefitinib and simvastatin into MDR HCC: impact of compositions on cell death, JNK3, and Telomerase.}, author={Harisa GI and Alzhrani RF and Alluhaidan AA and Alamri SM and Bakheit AH and Asiri HH and Attia SM}, journal={Oncol Res}, volume={33}, number={2}, pages={477-492}}"}}, {"_id": "35406712", "pmid": 35406712, "pmcid": "PMC8997834", "title": "Simvastatin Prevents Liver Microthrombosis and Sepsis Induced Coagulopathy in a Rat Model of Endotoxemia", "journal": "Cells", "authors": ["La Mura V", "Gagliano N", "Arnaboldi F", "Sartori P", "Procacci P", "Denti L", "Liguori E", "Bitto N", "Ristagno G", "Latini R", "Dondossola D", "Salerno F", "Tripodi A", "Colombo M", "Peyvandi F"], "date": "2022-03-29T00:00:00Z", "doi": "10.3390/cells11071148", "meta_date_publication": "2022 Mar 29", "meta_volume": "11", "meta_issue": "7", "meta_pages": "", "score": 50249.715, "text_hl": "Another limitation is that we do not know whether the observed pharmacologic effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ apply to other statins. ", "citations": {"NLM": "La Mura V, Gagliano N, Arnaboldi F, Sartori P, Procacci P, Denti L, Liguori E, Bitto N, Ristagno G, Latini R, Dondossola D, Salerno F, Tripodi A, Colombo M, Peyvandi F. Simvastatin Prevents Liver Microthrombosis and Sepsis Induced Coagulopathy in a Rat Model of Endotoxemia Cells. 2022 Mar 29;11(7):. PMID: 35406712", "BibTeX": "@article{35406712, title={Simvastatin Prevents Liver Microthrombosis and Sepsis Induced Coagulopathy in a Rat Model of Endotoxemia}, author={La Mura V and Gagliano N and Arnaboldi F and Sartori P and Procacci P and Denti L and Liguori E and Bitto N and Ristagno G and Latini R and Dondossola D and Salerno F and Tripodi A and Colombo M and Peyvandi F}, journal={Cells}, volume={11}, number={7}}"}}, {"_id": "40971053", "pmid": 40971053, "title": "Folate- and chitosan-functionalized lipid nanoparticles for co-delivery of pioglitazone and simvastatin to enhance hepatic cancer therapy: effects on IL-1beta, IL-6, BCL2/BAX gene expression, and GPX4, COX-2, and MMP-9 activities.", "journal": "Mol Biol Rep", "authors": ["Alzahrani RF", "Almuqati MS", "AlAli SA", "Alamer KA", "Rabbani S", "Alqahtani MS", "Bakheit AH", "Asiri HH", "Harisa GI"], "date": "2025-09-19T00:00:00Z", "doi": "10.1007/s11033-025-11011-2", "meta_date_publication": "2025 Sep 19", "meta_volume": "52", "meta_issue": "1", "meta_pages": "926", "score": 50248.242, "text_hl": "This study evaluated a nanotechnology-based co-delivery approach to improve their therapeutic efficacy against chemoresistant @<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@HCC@@@. METHODS AND RESULTS: @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@Lipid@@@ nanoparticles (LNPs) encapsulating @CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@PIO@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@STAT@@@ (PSLNPs) were fabricated and functionalized with @CHEMICAL_Chitosan @CHEMICAL_MESH:D048271 @@@chitosan@@@ (CPSLNPs) or @CHEMICAL_Folic_Acid @CHEMICAL_MESH:D005492 @@@folate@@@-conjugated @CHEMICAL_Chitosan @CHEMICAL_MESH:D048271 @@@chitosan@@@ (FCPSLNPs). ", "citations": {"NLM": "Alzahrani RF, Almuqati MS, AlAli SA, Alamer KA, Rabbani S, Alqahtani MS, Bakheit AH, Asiri HH, Harisa GI. Folate- and chitosan-functionalized lipid nanoparticles for co-delivery of pioglitazone and simvastatin to enhance hepatic cancer therapy: effects on IL-1beta, IL-6, BCL2/BAX gene expression, and GPX4, COX-2, and MMP-9 activities. Mol Biol Rep. 2025 Sep 19;52(1):926. PMID: 40971053", "BibTeX": "@article{40971053, title={Folate- and chitosan-functionalized lipid nanoparticles for co-delivery of pioglitazone and simvastatin to enhance hepatic cancer therapy: effects on IL-1beta, IL-6, BCL2/BAX gene expression, and GPX4, COX-2, and MMP-9 activities.}, author={Alzahrani RF and Almuqati MS and AlAli SA and Alamer KA and Rabbani S and Alqahtani MS and Bakheit AH and Asiri HH and Harisa GI}, journal={Mol Biol Rep}, volume={52}, number={1}, pages={926}}"}}]}